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Summary Increased fibre intake has been shown to reduce serum oestrogen concentrations. We hypothesized thatfibre exerts this effect by
decreasing the time available for reabsorption of oestrogens in the colon. We tested this in volunteers by measuring changes in serum
oestrogen levels in response to manipulation of intestinal transit times with senna and loperamide, then comparing the results with changes
caused by wheat bran. Forty healthy premenopausal volunteers were placed at random into one of three groups. The first group took senna
fortwo menstrual cycles then, after awashout period, took wheat bran, again fortwo menstrual cycles. The second group did the reverse. The
third group took loperamide for two menstrual cycles. At the beginning and end of each intervention a 4-day dietary record was kept and
whole-gut transit time was measured; stools were taken for measurement of pH and j-glucuronidase activity and blood for measurement of
oestrone and oestradiol and their non-protein-bound fractions and of oestrone sulphate. Senna and loperamide caused the intended
alterations in intestinal transit, whereas on wheat bran supplements there was a trend towards fastertransit. Serum oestrone sulphate fell with
wheat bran (mean intake 19.8 g day-') and with senna; total- and non-protein-bound oestrone fell with senna. Nosignificantchanges in serum
oestrogens were seen with loperamide. No significant changes were seen in faecal 3-glucuronidase activity. Stool pH changed only with
senna, in which case it fell. In conclusion, speeding up intestinal transit can lower serum oestrogen concentrations.
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There is substantial experimental, epidemiological and clinical
evidence that breast cancer risk is influenced by endogenous
hormones.
Breast cancer is less common in rural Third World communities
than in developed countries (Lea, 1966; Drasar and Irving, 1973;
Armstrong and Doll, 1975; Miller, 1977) and becomes more
common on migration from low- to high-risk areas, even within
one generation (Staszewski and Haenszel, 1965; Buell, 1973),
implying that environmental factors are important. Case-control
studies have shown low fibre intake, with or without high fat
intake, to be associated with increased risk of breast cancer
(Katsouyanni et al, 1986; Lubin et al, 1986; Howe et al, 1990;
Zaridze et al, 1991). How such diets exert this influence has not
been established, but one possibility is by an effect on oestrogen
metabolism.
A high-fibre diet (Feng et al, 1993), or addition ofwheat bran to
the diet ofhealthy women (Rose et al, 1991), has been reported to
reduce serum oestrogen levels. In rats given bran there was an
increase in stool oestrogen (Neale, 1983). Vegetarians have higher
faecal excretion and lower urinary excretion of oestrogens than
omnivores (Armstrong et al, 1981; Goldin et al, 1982; Gorbach
and Goldin, 1987). Plasma oestrogens have been found to be lower
in vegetarians than omnivores in some (Shultz and Leklem, 1983)
but not all studies (Goldin et al, 1982).
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Oestrogens excreted in the bile undergo enterohepatic recir-
culation. Deconjugation is believed to occur in the distal small
bowel and especially the colon, where bacteria containing
J-glucuronidase abound. Reduction in the bacterial flora with
antibiotics increases faecal excretion of both conjugated and
unconjugated oestrogens and reduces urinary and serum oestro-
gens (Willman and Pulkkinen, 1971; Martin et al, 1975;
Adlercreutz et al, 1977). These observations emphasize the role of
the colon in the enterohepatic circulation ofoestrogens.
We hypothesized that transit time is a rate-limiting factor in
oestrogen absorption from the colon, so that changes in colonic
transit rate affect the proportion of oestrogen that is deconjugated
and/or absorbed. Most forms of dietary fibre are laxative and
speed up colonic transit (Cummings, 1993). If faster colonic
transit does indeed lead to areduction in oestrogen absorption, this
could explain how wheat bran or a high-fibre diet reduces serum
oestrogens. A laxative might also act indirectly by reducing the
absorption of short-chain fatty acids [produced by fermentation
of unabsorbed starch and other carbohydrates, including
non-starch polysaccharide (NSP)] and so acidifying the colon.
As glucuronides are less well absorbed than unconjugated oestro-
gens, acidifying the colon and thus inhibiting 3-glucuronidase
activity (Kim et al, 1992) should decrease reabsorption. Previous
work has shown a decrease in faecal f-glucuronidase activity with
an increase in dietary fibre (Goldin and Gorbach, 1976; Goldin et
al, 1982; Reddy et al, 1989) and in vegetarians compared with
omnivores (Goldin et al, 1982).
The primary aims of this study were to find out whether the
reported reduction in serum oestrogens caused by wheat bran
ingestion could be confirmed and whether it could be emulated by
a chemical laxative, senna; and, conversely, whether an increase in
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Figure 1 Experimental design for each of the three groups
serum oestrogens occurs when colonic transit is slowed down
using loperamide. An additional aim was to assess whether alter-
ations in colonic transit rate lead to changes in faecal pH and
P-glucuronidase activity.
PARTICIPANTS AND METHODS
Forty healthy omnivorous female volunteers with regular
menstrual cycles were recruited by advertisements placed in local
hospitals. None was obese or had lactated within the last 12
months and none had taken oral contraceptives or antibiotics
within the last 3 months. None had a significant medical history or
a history offamilial breast disease.
At initial interview the aims ofthe project and the commitments
required were explained, a medical history was taken and height,
weight, waist and hip circumference were recorded. Subjects were
placed, at random, in three groups (Figure 1). Group A (ten
women), took senna (Senokot, Reckitt & Coleman) for two
menstrual cycles and, after a two-menstrual-cycle rest, took raw
wheat bran (American Association of Cereal Chemists) for a
further two cycles. Group B (ten women) took wheat bran, then
senna, the reverse of group A. These interventions aimed to reduce
bowel transit time as much as possible without causing discomfort.
Group C (20 women) took loperamide (Imodium, Janssen
Pharmaceuticals) for two cycles to increase bowel transit time as
much as acceptable. The subjects' compliance with the wheat bran
and tablets was assessed by weighing the returned wheat bran or
counting the tablets at the end of the study. Subjects recorded
times of defecation and the 'form' of each stool on a seven-point
scale (O'Donnell et al, 1990; Probert et al, 1993), ranging from the
discrete lumps ofslow transit (type 1) to the non-cohesive (type 6)
and liquid stools (type 7) of rapid transit. The amounts of wheat
bran (taken in portions through the day), senna and loperamide
(both taken at night) were adjusted by the subject to achieve a
change in stool form in the desired direction.
Venous blood was taken before 09.00 h after an overnight fast
on day 6 of each subject's menstrual cycle. Serum was stored at
-70°C until analysed.
Interventions were commenced after initial assessment of diet,
whole-gut transit time, serum oestrogen concentrations, stool pH
and stool ,-glucuronidase activity. The supplements were continued
until the same datahad been collected at the end ofthe experimental
phases comprising two complete menstrual cycles (Figure 1).
A dietary record was kept for two weekdays and two weekend
days at the start and end of each interventional period; a further
2-day record was kept midway through each intervention. Subjects
were asked to write down the type and amount offoods eaten, using
scales or household measures to gauge portion sizes where possible.
When necessary the subjects were contacted for a fuller description
of the items. Consumption of cigarettes and alcohol was also
recorded. Volunteers were encouraged to keep their diets, alcohol
intake, smoking and exercise patterns constant during the entire
experiment. At the end ofeach intervention volunteers were tactfully
asked ifthey had, after all, changed their diets over the study period.
The records were analysed forindividual nutrients [total energy, total
dietary fibre (Southgate), insoluble non-starchpolysaccharide (NSP),
soluble NSP, total NSP, total fat, saturated fat, polyunsaturated fat,
protein, carbohydrate, extrinsic sugar and alcohol] using a computer
programe based on McCance and Widdowson's The Composition of
Foods (Paul and Southgate, 1978) and on published values for NSP
(Englyst et al, 1988; Englyst et al, 1989).
Before and at the end of each intervention period whole-gut
transit time (WGTT) was measured using swallowed radiopaque
marker pellets and radiographing stools using a standard method-
ology (Lewis et al, 1996).
On passing their stools into a container, volunteers immediately
putthem in afridge. Within 12 h ofpassing, the stools were weighed
and the second stool was liquidized, tested for pH, then frozen at
-20°C for subsequent measurement of 0-glucuronidase activity.
Stool output per week was calculated as the mean weight ofthe two
stools multiplied by the stated number ofdefecations per week.
The volunteers were contacted weekly to answer queries,
provide encouragement and monitor their progress.
The study was approved by the Research Ethics Committee of
the United Bristol Healthcare Trust.
Serum analysis
Oestradiol, oestrone and oestrone sulphate
Oestradiol and oestrone were measured separately by selective
radioimmunoassay after extraction from the sample with organic
solvent. Only oestrone was found to cross-react (10%) with the
oestradiol assay; no interference was detected with the oestrone
assay. Accuracies were >87%. Precision (as coefficient ofvariation)
ofthe oestrone assay was 8% at273 pmol 1-1 and 13% at593 pmol 1-';
for oestradiol it was 13% at 167 pmol 1-' and 14% at 335 pmol 1-'.
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Table 1 Median whole-gut transit time and faecal measurements before and in the last week of each interventional perod (median, interquartile range, 95% Cl
and P-value of the difference between active and baseline measurements)
Baseline 10 range Active 10 range 95% Cl P-value
Whole-gut transit time (h)
Wheat bran 73.5 (42.8, 98.6) 52.9 (39.2, 70.9) (-29.4, 0.3) 0.061
Senna 68.7 (55.7, 74.6) 51.8 (40, 59.7) (-26.8,-9.2) 0.001
Loperamide 53.4 (48.1, 67.9) 69.2 (56.5, 79.6) (0.0, 26.4) 0.007
Calculated stool output (g week-')
Wheat bran 938 (594,1142) 1375 (649,1860) (-43, 726) 0.098
Senna 745 (370,1252) 1197 (750,1759) (216, 648) 0.001
Loperamide 1145 (718,1657) 800 (489,1021) (-848, -100) 0.033
Defecations per week
Wheat bran 7 (5, 8) 8 (7,10) (0.5, 3.0) 0.014
Senna 7 (5, 8) 8 (7,10) (0.6, 2.3) 0.002
Loperamide 7 (6.3, 9) 5 (4, 6) (-4.5,-1.9) <0.001
Baseline s.d. Active s.d. 95% Cl PLvalue
Stool form score (mean s.d.)
Wheat bran 3.54 0.98 4.7 0.85 (0.78,1.53) <0.001
Senna 3.51 1.00 4.41 0.98 (0.45,1.36) <0.001
Loperamide 3.68 0.79 2.7 0.97 (-1.3, -0.66) < 0.001
Oestrone sulphate was hydrolysed enzymatically as previously
described (McGarrigle and Lachelin, 1983) and the liberated
oestrone was measured by radioimmunoassay following Sephadex
LH 20 chromatography. Recoveries averaged 74%. Interassay
coefficients of variation for two plasma pools (1076 and
1855 pmol 1-1) were 14.6% and 12.3% respectively. The sensitivity
ofthe assay was 80 pmol 1-1.
Sexhormone-binding globulin, albumin andnon-protein
boundoestrogen
Sex hormone-binding globulin, adsorbed from the sample with
conconavalin A-Sepharose, was measured (Whittaker et al, 1992).
The serum albumin concentration was determined using
reagents supplied by Boehringer Mannheim on a Hitachi 747
automated analysis system.
The concentrations of non-protein-bound oestrone and non-
protein-bound 17f-oestradiol in each sample were calculated
(Speight et al, 1979) using the measured values for oestradiol,
oestrone, SHBG and albumin.
Stool analysis
Stool pH was measured after homogenization with a Jenway
PHM 6 BDH Gelplas combination pH electrode probe. Stool
,-glucuronidase activity was determined from the rate of
hydrolysis ofp-nitrophenol-oi-D-glucuronide (Mallet et al, 1985).
Activity was calculated from the linear part of the progress curve
using an extinction coefficient of 18.3 dm3 mmol-' cm-'. The
enzyme activity was expressed as mmol of substrate (p-nitro-
phenol-p-D-glucuronide) cleaved perhourby 1 g offaeces at 37°C
and pH 7.
Statistics
Serum oestrogen concentrations and stool0-glucuronidase activity
were analysed as logl0 transformed data, with results expressed as
geometric means and 95% confidence interval of the ratio of the
geometric means. Preintervention data were assessed asparametri-
cally or non-parametrically distributed using histograms and Ryan
Joiner tests. The differences between pre- and post-intervention
readings were then analysed using two-tailed Student's t-tests, or
Mann-Whitney tests as appropriate. Correlations were calculated
using Spearman's correlation coefficients.
RESULTS
Ofthe 40 women (mean age 35, s.d. 9 years) who entered the study,
36completedit.Twosubjectsin groupAand onein groupBdropped
outhalf-way through the study forpersonal reasons; and one woman
from group C dropped out because she became ill. There was no
significant difference between the groups in age, age at menarche,
parity, alcohol intake, smoking habit, height, weight, hip, waist
measurement orwaist-hipratio. The meanbody mass index ofgroup
A (21.4 kg m-2) was less than that of groups B (23.9 kg m-2) and
C (24.1 kg m-2, P = 0.031 and 0.016 respectively). Weight, hip and
waist circumference measurements did not alter over the study
period. Baseline anthropometric measurements, oestrogen levels
and WGTT of the three volunteers from groups A and B who
failed to complete were similar to those who did. The data gained
from their completed sections were included in the analysis.
Ingestion of senna and loperamide caused the intended changes
in WGTT, with corresponding changes in stool output, stool form
and defecatory frequency (Table 1). With wheat bran, stool form
and frequency clearly changed appropriately, whereas WGTT
tended to decrease and stool output to increase. Stool pH changed
only with senna, when it fell from 7.2 (s.d. 0.5) to 6.8 (s.d. 0.7)
(P = 0.04); stool I-glucuronidase activity was unaffected by any
intervention.
The serum concentrations of total and non-protein-bound
oestradiol failed to change with any ofthe interventions (Table 2).
However oestrone, both total and non-protein bound fractions, fell
in those taking senna. Decreases in the concentrations of oestrone
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Table 2 Oestradiol, sex hormone-binding globulin and albumin concentrations at the start and end of each interventional period (geometric mean, 95% Cl, 95%
Cl of the ratio of the geometrc means and P-value)
Baseline 95% Cl Active 95% Cl 95% Cl of the ratio P-value
Oestradiol (pmol 1-')
Wheat bran 281.1 (212.7, 371.5) 262.0 (199.3, 344.5) (-1.31, 1.14) 0.48
Senna 261.1 (194.2, 351.1) 225.8 (175.0, 291.3) (-1.50,1.13) 0.28
Loperamide 233.1 (184.8, 293.9) 248.6 (189.5, 326.2) (-1.25, 1.43) 0.64
Calculated non-protein-bound oestradiol (pmol 1-')
Wheat bran 5.5 (4.2, 7.1) 5.1 (4.0, 6.6) (-1.33, 1.16) 0.49
Senna 5.2 (4.1, 6.7) 4.5 (3.6, 5.6) (-1.52, 1.11) 0.22
Loperamide 4.5 (3.7, 6.2) 4.8 (3.7, 6.2) (-1.35,1.37) 0.96
Baseline IQrange Active IQ range 95% Cl of difference P-value
Sex hormone-binding globulin (nmol 1-')
Wheat bran 56.0 (39.5, 71.8) 51.5 (41.0, 77.3) (-6.5, 2.5) 0.31
Senna 44.0 (36.0, 65.0) 44.0 (38.0, 73.0) (-2.0, 5.0) 0.41
Loperamide 49.5 (43.3, 63.5) 52.5 (40.0, 68.0) (-4.0, 6.5) 0.86
Albumin (g 1-')
Wheat bran 44.0 (42.8, 45.0) 44.5 (40.0, 48.0) (0.0, 2.0) 0.09
Senna 44.0 (43.0, 46.0) 44.0 (43.0, 46.0) (-1.0,1.5) 0.93
Loperamide 42.0 (41.0, 45.0) 43.5 (42.0, 47.5) (-0.5, 3.5) 0.12
Table 3 Serum oestrone and oestrone sulphate concentrations at the start and end of each interventional penod (geometric mean, 95% Cl, 95% Cl of the ratio
of the geometric means and P-value)
Baseline 95%CI Active 95% Cl 95% Clof ratio P-value
Oestrone (pmol 1-')
Wheat bran 239.9 (193.9, 296.8) 246.1 (203.7, 297.4) (-1.13, 1.19) 0.72
Senna 252.1 (211.3, 300.7) 205.9 (179.5, 236.2) (1.05, 1.42) 0.01
Loperamide 219.3 (185.7, 258.9) 239.9 (192.6, 298.8) (-1.07,1.28) 0.24
Calculated non-protein-bound oestrone (pmol 1-')
Wheat bran 11.0 (8.7,13.0) 11.0 (9.0,13.0) (-1.14,1.20) 0.74
Senna 11.0 (9.8, 13.0) 9.2 (8.2, 10.0) (1.06,1.44) 0.01
Loperamide 6.7 (5.6, 8.0) 6.8 (5.6, 8.3) (-1.16,1.21) 0.78
Oestrone sulphate (pmol 1-')
Wheat bran 1744.6 (1412.5, 2154.3) 1523.3 (1256.3,1846.7) (1.00,1.31) 0.04
Senna 1833.2 (1529.0, 2198.0) 1647.4 (1391.6, 1950.7) (1.00,1.24) 0.04
Loperamide 1640.6 (1352.1, 1990.7) 1819.7 (1421.7, 2329.2) (-1.05,1.28) 0.18
sulphate were seen with wheat bran as well as senna (Table 3). No
changes in the oestrogens were observed in volunteers taking
loperamide (Tables 2 and 3). No changes were seen in SHBG and
albumin concentrations during any intervention (Table 2).
There was no significant difference between dietary intakes,
specifically total fibre, NSP, or fat, at the start, middle and end of
each interventional period. The mean baseline intake for the three
groups was 16.3 g day-' (s.d. 4.3) for fibre and 11.1 g day-'
(s.d. 2.8) for NSP. No volunteers reported a change in their diet.
Volunteers taking wheat bran consumed a mean of 19.8 g day-'
(s.d. 7.1), providing 9.1 g day-1 ofdietary fibre (Southgate, 1977)
and 8.1 g day-' ofNSP.
DISCUSSION
The subjects in this study can be considered sufficiently repre-
sentative. Their baseline dietary intake of fibre and its fractions
was greater than that reported for American adults (Anderson et
al, 1989), but similar to that of English women [21.5 g day-'
(Emmett et al, 1993) and 18.6 g day-' (Gregory et al, 1990)].
Their median whole-gut transit time (64 h) was very similar to
that (62 h) of a large group of healthy premenopausal women
(Probert et al, 1995) and their baseline stool outputs were in the
range of values (100-200 g day-') reported for UK women
(Wyman et al, 1978; Cummings et al, 1992). The intended
changes in bowel function occurred with all three supplements,
although the transit time change just escaped significance with
wheat bran.
Women ofreproductive age were studied because epidemiolog-
ical evidence links increased exposure to oestrone and oestradiol
to their subsequent development ofbreast cancer. Moreover, their
oestrogen concentrations are higher than after the menopause,
permitting more precise measurement and therefore enhanced
detection of changes in response to treatment. If our hypothesis
that intestinal transit speed is a determinant of serum oestrogen
concentration is correct, then this influence will occur in both pre-
and post-menopausal women. Samples for assay were collected
early in the follicular phase of the ovarian cycle. Alternative
sampling times such as at mid-cycle or in mid-luteal phase can
only be identified reliably in individuals after subsequent menstru-
ation. Use of such times would have required many more samples
to ensure the exact location ofthe peak levels.
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Table 4 Percentage change in early follicular serum oestrogens in this study and that of Goldin et al (1994)
Goldin et al This study
High fibre
Wheat bran Senna Loperamide
Non-protein bound oestradiol -4.9 -7.1 -17.5 0.0
Oestradiol -11.Oa -7.5 -15.7 +6.7
Oestrone -4.7 +2.5 -22.4a +8.8
Oestrone sulphate -17.1a -14.8a -12.2a +8.8
aP-value < 0.05.
The major finding of this study is that in subjects taking senna
serum concentrations ofoestrone and oestrone sulphate fell and on
wheat bran there was a decreased concentration of oestrone
sulphate. These findings support our hypothesis that faster
intestinal transit decreases the absorption of oestrogens thereby
reducing the exposure ofthe body tissues to oestrogens. It is likely
that the effect of senna is mediated via the colon as this laxative
has little or no effect on small bowel transit (Marcus and Heaton,
1986). The observation that the slower WGTT brought about by
loperamide did notresult in higher serum oestrogen concentrations
may imply that reabsorption is already maximal in British women
under normal conditions. The apparent lack of effect of bran on
WGTT may be misleading. In 7 ofthe 18 volunteers there was no
decrease in WGTT and hence a non-significant result forthe group
as a whole. Such variability in the response to bran has been
reported before (Eastwood et al., 1973). A laxative dose may not
be achieved ifbran causes bloating or excess flatus.
The present findings may be compared with those ofRose et al
(1991), who doubled the daily fibre intake (from 15 to 30 g day')
of 62 women by administration of additional wheat, oats or corn
bran for two menstrual cycles. Consumption ofwheatbran, but not
oats or corn, decreased the serum concentrations ofoestradiol and
oestrone in the early luteal phase. On combining dietary records
and oestrogen measurements before and after 2 months of inter-
ventions, a negative correlation was found between dietary fibre
intake and serum oestrone concentrations. However, subjects
consuming wheat bran also increased their energy, carbohydrate
and fat intake, and this may have influenced serum oestrogens.
A different protocol was used by Goldin et al (1994), who
measured early follicular phase serum oestrogen concentrations in
women on a high-fat/low-fibre diet (fat 40% ofcalories, fibre 12 g
day-') and on a low-fat/high-fibre diet (fat 20-25% of calories,
fibre 40 g day-') at constant calorie intake. From multiple regres-
sion analysis these authors concluded that an increase in fibre
intake decreased serum concentration of oestradiol and oestrone
sulphate but was without effect on oestrone.
The ability ofdietary fibre to alter intestinal transittime depends
on the type offibre and how it has been processed. In the study by
Rose etal. (1991), no transit or defecatory data were collected, but
oats and corn probably have less effect than wheat on intestinal
transit (Cummings, 1993). The fact that corn and oats bran had no
effect on serum oestrogens despite their ability to bind oestrogens
under experimental conditions (Shultz and Howie, 1986; Arts et al,
1991) suggests that the binding of oestrogens to bran is not an
important mechanism in the reduction of serum oestrogen concen-
trations. The use ofprocessed and cooked wheat bran by Rose et al
(1991) and Goldin et al. (1994) complicates any comparison with
the present study, in which only raw bran, a more effective laxative
(Wyman et al. 1976), was used. Despite these caveats, taken
together the three studies suggest that manipulation of colonic
function alters serum oestrogen levels (for example see Table 4).
Itis likely thatthe effects on serum oestrogens are brought about
by interference with the enterohepatic circulation. Rose et al,
(1991) invoked reduction of bacterial j-glucuronidase activity
and/or binding of oestrogens to explain their findings, whereas
Goldin et al (1994) offered no explanation for theirs. In our study
there was no change in stool ,-glucuronidase activity with any of
the dietary supplements used. Ingestion of senna was, however,
accompanied by a significant decrease in stool pH, and if this
reflected the pH ofthe colonic lumen then in vivo P-glucuronidase
activity might well have been reduced, leading to diminished
availability of unconjugated oestrogens for reabsorption. The
explanation wepreferis that, by speeding up transit, sennareduced
the time available for the hydrolysis and absorption of oestrogens
from the colon.
Which oestrogens are involved in the aetiology and promotion
of oestrogen-dependent diseases is not known. Moreover, the
biological importance of the changes in serum oestrone and
oestrone sulphate observed by us remains to be proved but, ifthey
are important, speeding up colonic transit might reduce the risk of
breast cancer in Western populations whose intestinal transit time
tends to be slow compared with that of rural Third World popula-
tions (Burkitt et al, 1972).
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